Abnormal levels of Aβ and tau protein phosphorylation in the brains of AD patients lead to plaque formation and NFTs, further activating microglia and inducing neuroinflammation, thereby promoting disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.